Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in the first trimester do not predict the subsequent development of preeclampsia.

"I wanted to identify if elevated levels of cell-free fetal DNA in maternal blood early in pregnancy could identify women at risk for the subsequent development of preeclampsia. I found that there is no significant difference in levels of total or free fetal DNA in the in women who subsequently develop preeclampsia," said Bob Silver, MD, with the University of Utah Health Sciences Center and Intermountain Healthcare, , in Salt Lake City, Utah. Silver conducted the study, entitled First Trimester Free Fetal DNA in The Maternal Circulation as a Predictor of .

More information: A copy of the abstract is available at www.smfmnewsroom.org/annual-me… 1-meeting-abstracts/

Provided by Society for Maternal-Fetal Medicine

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Pregnancy outcome affected by immune system genes

Oct 25, 2010

A team of researchers, led by Ashley Moffett, at the University of Cambridge, United Kingdom, has shed new light on genetic factors that increase susceptibility to and provide protection from common disorders of pregnancy, ...

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.